ROYALTY PHARMA PLC news, videos and press releases - Page 3
For more news please use our advanced search feature.
ROYALTY PHARMA PLC - More news...
ROYALTY PHARMA PLC - More news...
- Royalty Pharma to Present at Upcoming Investor Conferences
- Royalty Pharma To Announce Fourth Quarter And Full Year 2022 Financial Results On February 15, 2023
- Royalty Pharma Highlights Accomplishments and Provides Business Update at 41st Annual J.P. Morgan Healthcare Conference
- Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial Readiness
- Royalty Pharma Announces Dividend Increase
- Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 9
- Royalty Pharma Announces Expansion of Senior Leadership Team
- Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference
- Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran From Arrowhead for $250 million and Future Milestones
- Royalty Pharma to Announce Third Quarter 2022 Financial Results on November 8, 2022
- Royalty Pharma Declares Fourth Quarter 2022 Dividend
- Royalty Pharma Announces Expansion of Leadership Team
- Royalty Pharma Announces R&D Funding Collaboration With Merck
- Royalty Pharma to Present at Upcoming Investor Conferences
- Royalty Pharma Reports Second Quarter 2022 Results
- Royalty Pharma Declares Third Quarter 2022 Dividend
- Royalty Pharma to Announce Second Quarter 2022 Financial Results on August 4, 2022
- Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million
- Royalty Pharma Acquires Royalty Interest in Gavreto From Blueprint Medicines for up to $340 Million
- Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
- Royalty Pharma to Present at the UBS Global Healthcare Conference 2022
- Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders
- Royalty Pharma Declares Second Quarter 2022 Dividend
- Royalty Pharma to Announce First Quarter 2022 Financial Results on May 5, 2022
- Royalty Pharma to Present at Cowen's 42nd Annual Health Care Conference
- Royalty Pharma Announces Inaugural Investor Day
- Royalty Pharma Reports Q4 and Full Year 2021 Results
- Royalty Pharma to Announce Fourth-Quarter and Full-Year 2021 Financial Results on February 15, 2022
- Royalty Pharma Highlights Accomplishments and Provides Business Update at 40th Annual J.P. Morgan Healthcare Conference
- Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million
